Archives

by in
Entry Author Date Location
Why Not Test a Supply Chain Model? What We’ve Got Isn’t Working 05/31/13 San Diego
Assigning Credit and Blame to Biopharma R&D Chiefs 05/29/13 Seattle
Applying “Innovation Arbitrage” to Develop Novel Medicines in China 05/28/13 San Diego
Why the Kendall Square Lab and Office Markets Are Out of Whack 05/15/13 Boston
Supply Chains Are Orderly. Biotech Innovation Is Messy 04/30/13 Boston
Boston: Reclaiming Its Place as a Technology Hub 04/26/13 Boston
Can Biotech Learn From the TV Production Market? 04/26/13 National
The Devil is in the Details: What BioPharma Press Releases Don’t Say 04/24/13 Seattle
From Assets to Zen: Building Successful Drug Hunting Relationships 04/22/13 San Diego
Re-thinking Clinical Trials for the World of Crowdsourcing 04/16/13 Boston
Rewarding High-Risk Innovation: The Case for Carried Interest 04/15/13 San Diego
Strategies for Navigating the Life Sciences Capital Crunch 04/15/13 San Francisco
Lighting the Way to Better Understanding of the Brain 04/10/13 Seattle
Sequencing Seattle: An Idea for the Future of the Northwest 04/03/13 Seattle
SEC’s New Social Media Guidance: Sensible, Fair, Inevitable 04/03/13 National
ENCODE and the Truth 03/29/13 Seattle
Still Waiting for the Ships to Come in at Third Rock Ventures 03/28/13 San Diego
Build Credibility As You Build Your Business 03/26/13 Seattle
Drug Development: Let’s Play! 03/21/13 Seattle
Fighting a Global War on Rare Diseases 03/20/13 New York
Excess Healthcare Spending Is Undermining Innovation 03/19/13 Seattle
Has The Pendulum Swung Too Far in Favor of Rare Diseases? 03/14/13 Seattle
Four Things I Learned From Studying Innovation in 3 U.S. Cities 03/12/13 San Diego
Finding Parallels in Baseball and Drug Development 03/01/13 Seattle
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
The Academy Awards: Biopharma Edition 02/20/13 Seattle
Trends to Watch at This Year’s Big AGBT Meeting 02/20/13 National
Prostate Cancer Drug Winners and Losers at ASCO GU 02/15/13 National
Corporate Compliance Programs: The Importance of Being Effective 02/15/13 National
The Holy Grail of Drug Development: Small Molecules with the Power of Biologics 02/14/13 Boston
Page 3 of 10 « previous page · next page »